CONVERTIBLE DEBENTURES AND WARRANTS PURCHASE AGREEMENT Between Calypte Biomedical Corporation and the Investors Signatory HeretoRegistration Rights Agreement • April 13th, 2001 • Calypte Biomedical Corp • Laboratory analytical instruments • New York
CONVERTIBLE DEBENTURES AND WARRANTS PURCHASE AGREEMENT dated as of January 22, 2001 (the "Agreement"), between the Investors signatory hereto (each an "Investor" and together the "Investors"), and Calypte Biomedical Corporation, a corporation organized and existing under the laws of the State of Delaware (the "Company").
ESCROW AGREEMENTEscrow Agreement • April 13th, 2001 • Calypte Biomedical Corp • Laboratory analytical instruments • New York
THIS ESCROW AGREEMENT (this "Agreement") is made as of January 22, 2001 by and among Calypte Biomedical Corporation, a corporation incorporated under the laws of the State of Delaware (the "Company"), the investors signatory hereto (each an "Investor" and together the "Investors") and Epstein Becker & Green, P.C., (the "Escrow Agent"). Capitalized terms used but not defined herein shall have the meanings set forth in the Convertible Debentures and Warrants Purchase Agreement referred to in the first recital.
STOCK PURCHASE WARRANT To Purchase 200,000 Shares of Common Stock of Calypte Biomedical CorporationCalypte Biomedical Corp • April 13th, 2001 • Laboratory analytical instruments
THIS CERTIFIES that, for value received, AMRO International, S.A. (the "Holder"), is entitled, upon the terms and subject to the conditions hereinafter set forth, at any time on or after January 24, 2001 (the "Initial Exercise Date") and on or prior to the close of business on the third anniversary of the Initial Exercise Date (the "Termination Date"), but not thereafter, to subscribe for and purchase from Calypte Biomedical Corporation, a Delaware corporation (the "Company"), up to 200,000 shares (the "Warrant Shares") of Common Stock, $0.001 par value, of the Company (the "Common Stock"). The purchase price of one share of Common Stock (the "Exercise Price") under this Warrant shall be $1.50. The Exercise Price and the number of shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. In the event of any conflict between the terms of this Warrant and the Convertible Debentures and Warrants Purchase Agreement dated January 22, 2001 pursuant to whi
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 13th, 2001 • Calypte Biomedical Corp • Laboratory analytical instruments • New York
THIS REGISTRATION RIGHTS AGREEMENT, dated as of January 22, 2001, between the investor or investors signatory hereto (each an "Investor" and together the "Investors"), and Calypte Biomedical Corporation, a Delaware corporation (the "Company").
